The largest database of trusted experimental protocols

4 protocols using sitagliptin phosphate monohydrate

1

Sitagliptin Eye Drops for Diabetic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the age of 10 weeks, sitagliptin (sitagliptin phosphate monohydrate (Y0001812, Merck KGaA, Darmstadt, Germany)) eyedrops (10 mg/mL; n = 12) and vehicle (phosphate-buffered saline (PBS)) eyedrops (n = 12) were randomly administered twice per day directly onto the superior corneal surface of each eye of diabetic mice with the aid of a micropipette (5 µL). On day 15, animals (12 weeks of age) received one drop of sitagliptin or vehicle 1 h before euthanasia. Twelve non-diabetic mice, matched by age, were used as a control group.
+ Open protocol
+ Expand
2

In Vitro GLP-1 Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hydrofluoric acid (HF), α‐Linolenic acid, DPP4 inhibitor, DMEM, pancreatin, pepsin, lecithin, sodium taurocholate hydrate, DMSO, carboxymethylcellulose sodium (CMC), sitagliptin phosphate monohydrate, and GLP‐1 (active) ELISA kit (EGLP‐35K) for in vitro GLP‐1 analysis were purchased from Merck (Germany). Methanol, cell culture inserts, fetal bovine serum (FBS), horse serum, penicillin‐streptomycin, glutamine were acquired from Thermo Fisher Scientific Inc. (Denmark). D‐ (+)‐Glucose was obtained from VWR International Oy (Finland), and EDTA‐coated capillary (Minivette POCT) was bought from SARSTEDT Oy (Finland). For measuring plasma active GLP‐1 level of mice, active GLP‐1 ELISA kits (293‐79301) were purchased from FUJIFILM Wako Pure Chemical Co. (Japan). Silicon wafers were purchased from Siegert Wafer GmbH (Germany), while ethanol (EtOH) was purchased from Altia Oyj (Finland).
+ Open protocol
+ Expand
3

Topical sitagliptin eye drops for diabetic mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Db/db mice aged 10 weeks received a topical ocular administration of 10 mg/mL sitagliptin phosphate monohydrate (Y0001812, Merck KGaA, Darmstadt, Germany) or vehicle eye drops [phosphate buffered saline (PBS)] for 2 weeks twice per day. Eye drops were randomly administered with the aid of a micropipette (5 µL), onto the superior corneal surfaces of both eyes of diabetic mice. On day 15, 1 h before euthanasia, animals received an additional dose of each treatment. Db/+ mice matched by age were used as the control group.
+ Open protocol
+ Expand
4

Sitagliptin Eyedrops Affect Corneal Health

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sitagliptin [sitagliptin phosphate monohydrate (Y0001812, Merck KGaA, Darmstadt, Germany) eyedrops (10 mg/mL; 5 µL; n = 12) or vehicle [phosphate buffered saline (PBS)] eyedrops (5 µL; n = 12) were randomly administered directly onto the superior corneal surface of each eye using a micropipette in 10-week-old mice. The treatment (sitagliptin or vehicle) was administered twice daily for 15 days. Non-diabetic mice (n = 12) matched by age were used as control group. On day 15, the drop of sitagliptin or vehicle was administered animals 1h before euthanasia.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!